Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Europe stocks sink as U.S. debt ceiling talks stumble and UK inflation drops less than forecast
🌱🧀 Craving a vegan twist on the ultimate comfort food? @VegNews has cracked the code with their guide to drool-worthy boxed mac and cheese https://t.co/PFxYmprTHY! 🤤 But hold on tight, because we've taken it up a notch with a whole arsenal of mouthwatering mac and cheese…
— PlantX (@goplantx) May 23, 2023
Good alert
$AVRO gets $87.5 Million to Sell Cystinosis Gene Therapy Program
All-cash transaction, with full $87.5 million to be paid at closing
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
All-cash transaction, with full $87.5 million to be paid at closing
Proceeds expected to extend cash runway into Q4 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced an agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis to Novartis for $87.5 million in cash. AVROBIO retains full rights to its portfolio of first-in-class HSC gene therapies for Gaucher disease type 1 and type 3, Hunter syndrome and Pompe disease. Proceeds from this transaction are expected to extend the Company’s cash runway into the fourth quarter of 2024. “This transaction strengthens AVROBIO’s balance sheet, focuses our pipeline strategy and is a strong endorsement of our HSC gene therapy approach and plato® gene therapy platform,” said Erik Ostrowski, AVROBIO’s interim CEO and current CFO.
Transaction details
Pursuant to the terms of an asset purchase agreement, Novartis will pay AVROBIO $87.5 million in cash at closing, in consideration for the sale and transfer of certain assets related to the cystinosis program. In addition, AVROBIO has exclusively licensed to Novartis certain other assets, know-how and other intellectual property related to AVROBIO’s gene therapy platform for use in cystinosis. To support the transition of the program, AVROBIO also has agreed to provide under a separate agreement certain transition, knowledge transfer and other related services. TD Cowen and Wells Fargo Securities, LLC are acting as financial advisors to AVROBIO in the transaction.
$AVRO on high alert
Good Morning MATRIX
Blue #MATRIX
Red or blue
Good Morning #MATRIX
Good Morning #MATRIX
Solid news $VTXB
$VTXB to Launch #AI Bot for #BTC Trading and Mining
https://www.prnewswire.com/news-releases/vortex-brands-co-to-launch-ai-bot-for-bitcoin-trading-and-mining-301824265.html
Yo yo matrix
Good Evening #MATRIX
Churning nicely
Lfg $VTXB
$VTXB #POURHOUR
Vortex Brands Co. ($VTXB): $VTXB Doubles Its #BTC Mining Capacity i... https://t.co/EHJieGdiZv via @Investors_Hub
— Anita Dump (@stocksandredsox) May 9, 2023
New COO and CEO $TREN
$TREN revamping CEO and COO hmm
$TREN - Trend Innovations Holding, Inc. Appoints Paul Averill as Chief Operating Officer **
LAS VEGAS, NV / ACCESSWIRE / May 2, 2023 / Trend Innovations Holding, Inc. (OTCQB:TREN) ( "Trend" or the "Company"), a technology holdings company specializing in acquiring, creating, and developing innovative and advanced technologies utilizing artificial intelligence (AI) as well as providing...
View the full press: https://marketwirenews.com/news-releases/trend-innovations-holding-inc-appoints-paul-averill--8208727295156013.html
$TREN had more news today
$AVOI had a change of control this week... Shell bought, debt free and shares are maxed out..
~ Filings: Pink Current - Transfer Agent Verified
~ Undiscovered on Web/Social Media! Getting found soon.
~ Luv getting in these plays early... That is when the big money is made
~ Bet it wont be long to find out what is coming in here. They paid $305,682
Lead person at that company is Debbie J. Rasmussen, 2321 East Escondido, Gilbert, AZ 85234
She owns a $2M, 6K Sq Ft Home, so is relatively wealthy.
$BIEL MedPharm Publications:
Chronic pain management gets a new impact player
$TREN Trending: Trend Innovations Holding, Inc. Appoints Kenneth L. Waggoner as Chief Executive Officer
$TREN Trending: Trend Innovations Holding, Inc. Appoints Kenneth L. Waggoner as Chief Executive Officer https://t.co/Lzhnla01Cf
— Market Wire News (@marketwirenews) April 25, 2023
#MWN #TuesdayTip @bthefirsttoknow @FlashAlert_me @TaylorB16445829 @ABetterInnovat1 @resx18 @JRyanGlenn $JUPW $DPRO $TREN $BKTI
$TREN Short Information https://t.co/TfAJOewRhO
— Market Wire News (@marketwirenews) April 25, 2023
#MWN #TuesdayTip @FlashAlert_me @AccesswireNews @resx18 @bthefirsttoknow @TaylorB16445829 $JUPW $DPRO $TREN $BKTI
$BBBY BREAKING NEWS: Bed Bath & Beyond says it has filed for bankruptcy protection, but its stores and websites will remain open.
https://newjersey.news12.com/struggling-bed-bath-beyond-files-for-bankruptcy-protection?fbclid=IwAR1uyZp-a-DHfANCasan5ZBHdtvR2ZCrHu2g2-SWbj3KPvGs48dGjbEMASw?region=newjersey
$TREN Enhancing Its Artificial Intelligence Platform to Offer Improved More Robust User-Friendly Experience
https://marketwirenews.com/news-releases/trend-innovations-holding-enhancing-its-artificial-i-6886240761794074.html?t=557366
Text ASKSLAP to 84483 to receive portfolio alerts ..
#crypto #stocks
$TREN Newly Acquired AI Technology Successfully Proves It's Highly Effective in Real-Time Cybersecurity Incidents
https://marketwirenews.com/news-releases/trend-innovations-holding-s-tren-newly-acquired-ai-t-5211671497076260.html
Gonna be a wild week. Just sayin. pic.twitter.com/P0iQ71pFG6
— Jay Downing (@TradrJay) April 9, 2023
$TREN Acquires Two Technologies In Multi-Billion Dollar Markets - AI Machine Learning & Digital Artworks Markets • TREN • Apr 4, 2023 6:00 AM
https://marketwirenews.com/news-releases/trend-innovations-acquires-two-technologies-in-ai-ml-5498651911288255.html
$HWAL Announces the Completion of Audit(s) 2021 and 2020
https://marketwirenews.com/news-releases/hollywall-entertainment-inc-otc-hwal-announces-the-c-7004042751309839.html
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |